| Bioactivity | Lumateperone metabolite 1 (Formula T) is a metabolite of Lumateperone (HY-17637)[1]. Lumateperone (ITI-007) is an orally active 5-HT2A receptor antagonist (Ki = 0.54 nM), a partial agonist of presynaptic D2 receptors and an antagonist of postsynaptic D2 receptors (Ki = 32 nM), and a dopamine D1 receptor modulator[2][3] |
| CAS | 1469777-40-9 |
| Formula | C23H28FN3O |
| Molar Mass | 381.49 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Sharon Mates, et al. Organic compounds. WO2015154025A1. [2]. Jinyuan Zhang, et al. Identification of Trovafloxacin, Ozanimod, and Ozenoxacin as Potent c-Myc G-quadruplex Stabilizers to Suppress c-Myc Transcription and Myeloma Growth. Mol Inform. 2022 Mar 30:e2200011. [3]. J Titulaer, et al. Lumateperone-mediated effects on prefrontal glutamatergic receptor-mediated neurotransmission: A dopamine D1 receptor dependent mechanism. Eur Neuropsychopharmacol. 2022 Jul 22;62:22-35. |
Lumateperone metabolite 1
CAS: 1469777-40-9 F: C23H28FN3O W: 381.49
Lumateperone metabolite 1 (Formula T) is a metabolite of Lumateperone (HY-17637). Lumateperone (ITI-007) is an orally ac
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.